Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDABVC BioPharma Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.40 | -$0.40 | -$0.40 |
| Q2 2026 | 1 | -$0.40 | -$0.40 | -$0.40 |
| Q1 2027 | 1 | -$1.25 | -$1.25 | -$1.25 |
| Q2 2027 | 1 | -$2.00 | -$2.00 | -$2.00 |
| Q3 2027 | 1 | -$1.50 | -$1.50 | -$1.50 |
| Q4 2027 | 1 | -$0.50 | -$0.50 | -$0.50 |
| Q1 2028 | 1 | -$0.60 | -$0.60 | -$0.60 |
| Q2 2028 | 1 | -$0.40 | -$0.40 | -$0.40 |
| Q3 2028 | 1 | -$0.50 | -$0.50 | -$0.50 |
ABVC BioPharma Inc Earnings Date And Information
ABVC BioPharma Inc last posted its earnings results on Wednesday, March 13th, 2024. The company reported $-0.35 earnings per share for the quarter, topping analysts' consensus estimates of $-0.5 by $0.15. The company had revenue of -795,950 for the quarter and had revenue of 795.95 K for the year. ABVC BioPharma Inc has generated $0 earnings per share over the last year ($-0.39 diluted earnings per share) and currently has a price-to-earnings ratio of -3.15. ABVC BioPharma Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
ABVC BioPharma Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/03/2026 | Q4 2025 | N/A | $0.13 | N/A | N/A | $-795,950 |
| 10/31/2025 | Q3 2025 | N/A | -$0.05 | N/A | N/A | $795.95 K |
| 08/13/2025 | Q2 2025 | N/A | -$0.13 | N/A | $300.00 K | $0 |
| 04/30/2025 | Q1 2025 | N/A | -$0.06 | N/A | $300.00 K | $0 |
| 04/15/2025 | Q4 2024 | N/A | $0.02 | N/A | N/A | $1.97 K |
| 11/14/2024 | Q3 2024 | N/A | -$0.02 | N/A | $26.44 K | $389.28 K |
| 08/14/2024 | Q2 2024 | N/A | -$0.08 | N/A | $26.18 K | $117.14 K |
| 05/17/2024 | Q1 2024 | N/A | -$0.29 | N/A | $25.92 K | $1.21 K |
| 03/13/2024 | Q4 2023 | -$0.50 | -$0.44 | 0.06 | N/A | $2.17 K |
| 11/15/2023 | Q3 2023 | -$0.40 | -$0.82 | -0.42 | N/A | $15.88 K |
| 08/14/2023 | Q2 2023 | -$0.60 | -$0.68 | -0.08 | N/A | $6.11 K |
| 05/15/2023 | Q1 2023 | -$0.50 | -$0.55 | -0.05 | N/A | $128.27 K |
| 03/31/2023 | Q4 2022 | -$1.90 | -$1.51 | 0.39 | N/A | $588.99 K |
| 11/14/2022 | Q3 2022 | -$2.00 | -$1.14 | 0.86 | N/A | $42.27 K |
| 08/15/2022 | Q2 2022 | -$2.00 | -$0.59 | 1.41 | N/A | $312.86 K |
| 05/16/2022 | Q1 2022 | N/A | -$2.00 | N/A | N/A | $25.66 K |
| 03/31/2022 | Q4 2021 | -$0.04 | -$3.05 | -3.01 | N/A | $-37,793 |
| 11/15/2021 | Q3 2021 | -$0.40 | -$0.70 | -0.3 | N/A | $99.00 K |
| 08/11/2021 | Q2 2021 | -$0.04 | -$0.80 | -0.76 | N/A | $31.44 K |
| 05/10/2021 | Q1 2021 | N/A | -$0.50 | N/A | N/A | $263.15 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ABVC BioPharma Inc Earnings: FAQ's
In the previous quarter, ABVC BioPharma Inc (:ABVC) reported $-0.35 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.5 by $0.15.
The conference call for ABVC BioPharma Inc's latest earnings report can be listened to online.
The conference call transcript for ABVC BioPharma Inc's latest earnings report can be read online.
ABVC BioPharma Inc (:ABVC) has a recorded annual revenue of $795.95 K.
ABVC BioPharma Inc (:ABVC) has a recorded net income of $-7,908,554.ABVC BioPharma Inc has generated $-0.39 earnings per share over the last four quarters.
ABVC BioPharma Inc (:ABVC) has a price-to-earnings ratio of -3.15 and price/earnings-to-growth ratio is -0.12.